CYTK
Closed
Cytokinetics Inc
33.64
+0.60 (+1.82%)
Last Update: 01 Jul 2025 23:02:00
Yesterday: 33.04
Day's Range: 32.66 - 34.38
Send
sign up or login to leave a comment!
When Written:
35.19
Cytokinetics Inc. is a biopharmaceutical company that develops muscle biology-based therapies for diseases and medical conditions. The company's lead drug candidate is omecamtiv mecarbil, a cardiac myosin activator that is being developed in collaboration with Amgen for the treatment of heart failure. Cytokinetics also has several other drug candidates in various stages of development for the treatment of skeletal muscle disorders, including spinal muscular atrophy and amyotrophic lateral sclerosis. The company was founded in 1997 and is headquartered in South San Francisco, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








